Express Scripts sues FTC over drug pricing report

Pharmacy benefit manager Express Scripts sued the U.S. Federal Trade Commission on Tuesday over the regulator's recent drug pricing report, calling the report's conclusion that the prescription middlemen raise drug costs defamatory.

Sign up for Reuters newsletters Reuters Business Reuters Business

Express Scripts sues FTC over drug pricing report

Global defensive sector funds see surge in inflows on slowdown fears

Morning Bid: New highs, rotation as Fed meets with retail healthcheck

Futures rise with economic data, Fed's rate-cut decision on tap

Big Tech, calls for looser rules await new EU antitrust chief

Kroger-Albertson's US anti-trust trial to end but other legal blocks loom

Ignoring risk, investors still buying US junk debt with weak protections

US retailer holiday hiring set to be lower than last year

Fed rate cut uncertainties rattle balance sheet outlook

Bond investors debate recession risks with Fed easing finally at hand

Sponsors are not involved in the creation of newsletters or other Reuters news content. Advertise in this newsletter or on Reuters.com Reuters Business is sent every weekday. Think your friend or colleague should know about us? Forward this newsletter to them. They can also sign up here. Want to stop receiving this email? Unsubscribe here. To manage which newsletters you're signed up for, click here. Reuters Terms & Conditions and Privacy Statement

© 2024 Thomson Reuters. All rights reserved. 3 Times Square, New York, NY 10036